Metastatic Gastric Cancers Recruiting Phase 2 Trials for Ipilimumab (DB06186)

Also known as: Metastatic Gastric Cancer / Gastric cancer stage IV NOS / Gastric cancer stage IV / Malignant neoplasm of stomach stage IV NOS / Gastric malignancy stage IV NOS / Stomach cancer stage IV NOS

IndicationStatusPhase
DBCOND0063580 (Metastatic Gastric Cancers)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03409848Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric AdenocarcinomaTreatment